SCHEMBL5032590

SCHEMBL5032590

CCc1cccc(NC(N)=O)n1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.57
CHRNB2 P17787 2/20 0.53
CHRNB4 P30926 2/20 0.53
CHRNA3 P32297 2/20 0.53
CHRNA4 P43681 2/20 0.53
SYK P43405 2/20 0.47
PARP1 P09874 1/20 0.46
ATR Q13535 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
RAB9A P51151 1/20 0.43
MAPK8 P45983 1/20 0.43
CFD P00746 3/20 0.42
KCNH2 Q12809 1/20 0.41
XIAP P98170 1/20 0.41
BIRC2 Q13490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015666 0.87 NR3C2 (0.61) NR3C2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3111821 0.86 CHRNB2 (0.56) CHRNB2CHRNB4CHRNA3CHRNA4SYK
SCHEMBL7895323 0.84 MAPK8 (0.59) NR3C2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6361201 0.83 CHRNB2 (0.53) CHRNB2CHRNB4CHRNA3CHRNA4SYK
SCHEMBL9413728 0.81 MEN1 (0.55) NR3C2SMN1; SMN2RAB9AXIAPBIRC2
SCHEMBL91504 0.80 CHRNB2 (0.54) CHRNB2CHRNB4CHRNA3CHRNA4SYK
SCHEMBL11524453 0.80 CHRNB2 (0.45) NR3C2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL4171284 0.80 CHRNB2 (0.51) CHRNB2CHRNB4CHRNA3CHRNA4SYK
SCHEMBL10083508 0.80 CHRNB2 (0.51) NR3C2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL10082485 0.79 CHRNB2 (0.50) CHRNB2CHRNB4CHRNA3CHRNA4SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957485-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Healthcare, LLC (US) 2008-08-20 EP claimed
WO-2007064931-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2007-06-07 WO claimed